Cervix Neoplasms
14
0
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels
Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix
Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)
Cold Knife Conization With and Without Lateral Hemostatic Sutures
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
Healing Touch and Relaxation Therapies in Cervical Cancer Patients
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants
The IMAP Study Improving Management of Mildly Abnormal Pap Smears
Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?